Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

CRNX | NASDAQ
Chart Builder DCF Calculator
$84.95
$0.00 (0.00%)
At close: Aug 31, 2026, 4:00 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Oct 6, 2026
35.7
-0.7 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $9B
1D Range
84.95 84.95
52W Range
32.30 85.01

Valuation (TTM)

PE -16.82
PB 7.55
EV/EBITDA -15.42

Valuation (NTM)

Forward PE N/A
Forward PEG 1.87
Price Target $84.86
Loading financial charts...

Profile

Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent en...

Sector Healthcare
Industry Biotechnology
Employees 594
IPO Date Jul 18, 2018
Fiscal Year January - December

Latest News

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Tops Revenue Estimates

4 months ago · zacks.com

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Tops Revenue Estimates
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

4 months ago · globenewswire.com

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?

4 months ago · prnewswire.com

Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?
Why This Pharmaceutical Stock Jumped Close to 100% This Week

4 months ago · fool.com

Why This Pharmaceutical Stock Jumped Close to 100% This Week
Why Crinetics Stock Soared 99% This Week

4 months ago · 247wallst.com

Why Crinetics Stock Soared 99% This Week
Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?

4 months ago · zacks.com

Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)

4 months ago · newsfilecorp.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)
Samsung, Micron, Rivian, SpaceX, Crinetics, and More Stocks That Explain Today's Market

4 months ago · barrons.com

Samsung, Micron, Rivian, SpaceX, Crinetics, and More Stocks That Explain Today's Market
CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

4 months ago · businesswire.com

CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why

4 months ago · benzinga.com

Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why

Analyst Summary

# of Analysts
12
Consensus
Hold
Price Target
$85.00
Upside
+0.06%
Buy (4)
Hold (7)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.